Jayhawk Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$59.9M Sell
11,973,786
-776,214
-6% -$3.71M 100% 1
2019
Q3
$61.7M Sell
12,750,000
-507,627
-4% -$2.66M 100% 1
2019
Q2
$76.6M Sell
13,257,627
-167,792
-1% -$1.11M 100% 1
2019
Q1
$94.2M Sell
13,425,419
-453,412
-3% -$3M 100% 1
2018
Q4
$89.5M Buy
13,878,831
+1,075,681
+8% +$6.87M 100% 1
2018
Q3
$89.5M Sell
12,803,150
-2,173,350
-15% -$16.3M 100% 1
2018
Q2
$142M Hold
14,976,500
99.97% 1
2018
Q1
$153M Sell
14,976,500
-461,300
-3% -$4.71M 99.88% 1
2017
Q4
$153M Buy
+15,437,800
New +$169M 99.31% 1

Other funds holding CO

Jayhawk Capital Management's CO Position: Q4 2019 in Review

Jayhawk Capital Management reduced its Global Cord Blood Corporation (CO) stake by 6.1% in Q4 2019, selling an estimated $3.71M and leaving 11,973,786 shares worth $59.9M. The position accounts for 100% of the portfolio, ranked #1.

Jayhawk Capital Management first reported a position in CO in Q4 2017 and has held it in 9 quarters since. The position peaked at $153M in Q4 2017. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

  • Jayhawk Capital Management held 11,973,786 shares of Global Cord Blood Corporation worth $59.9M as of Q4 2019.
  • Jayhawk Capital Management sold 776,214 Global Cord Blood Corporation shares in Q4 2019, an estimated $3.71M.
  • Global Cord Blood Corporation made up 100% of Jayhawk Capital Management's portfolio in Q4 2019, its #1 holding.
  • Jayhawk Capital Management first reported a position in Global Cord Blood Corporation in Q4 2017 and has held it in 9 quarters since.
  • Jayhawk Capital Management's Global Cord Blood Corporation position peaked at $153M in Q4 2017.
  • 35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Jayhawk Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.